Peyronie's Disease

There is a be short of of consensus on the optimal timing and management of Peyronie's disease (PD). This stems in persuasive part from our limited understanding of the pathophysiology of the disorder and a requisite of well designed clinical trials of therapy. Poor common sense of PD is widespread even amongst urologists as suggested by a recent investigate.

Up to the itsy-bitsy research has dramatically increased our knowledge base and offers the role for newer and more productive treatments in the future. Unfortunately, it may be lone years before this new data becomes clinically relevant for the general urologist in practice. The purpose of this learn provisional on to was to determine how urologists in clinical practice are actually managing Peyronie's pester.

We rest that vitamin E was by far the most prescribed oral heal (selected by 70% of respondents) compared to the advance most commonly utilized enunciated therapy (Potaba®, chosen by 20%). Justifiable down half of urologists surveyed performed surgery for Peyronie's disablement, and 85% of these performed due 1-5 procedures per year. This suggests that extraordinarily few urologists are "considerable-volume" Peyronie's surgeons.With gratuity to management of our case presentations, the bulk of urologists favored observation and medical therapy for all patient presentations except for the example of punishing curvature associated with ED, for which surgical management was most dominant.

It was unblessed that our response rate was low and this obligates us to take our findings with the accepted "grain of salt" with respect to their generalizability to the larger majority of U.S. urologists. Nevertheless, our study suggests that current stewardship of PD amongst urologists is based more or less on the best present evidence with medical therapy the treatment of choice for non-violent disease or disease in its' active state and surgical intervention on the whole reserved for patients with severe, chronic phase plague. It is our hope that research in PD will continue and in the future stewardship of the patient with PD will be based on what is most invariably effective rather than on provider preference.